Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
11/2005
11/24/2005WO2004103271A3 Disease prevention and vaccination prior to thymic reactivations
11/24/2005WO2004078929A3 Materials and methods for identifying genes and/or agents that alter replicative lifespan
11/24/2005US20050260707 Corynebacterium glutamicum genes encoding metabolic pathway proteins
11/24/2005US20050260674 Specific polypeptides, useful as nematocides
11/24/2005US20050260673 nematode-specific gene products that can serve as targets for inhibitory peptides and proteins (e.g., antibodies) and antiparasitic chemicals
11/24/2005US20050260154 G-CSF analog compositions and methods
11/23/2005EP1598416A1 Method for producing L-amino acid
11/23/2005EP1597383A2 Variants of cytochrome c and methods of diagnosis of thrombocytopenia
11/23/2005EP1597356A2 Cultured cd14+ antigen presenting cells
11/23/2005EP1597354A2 System for external control of oncolytic virus replication
11/23/2005EP1597353A2 CIRCULATING TUMOR CELLS (CTC's): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS
11/23/2005EP1597352A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney
11/23/2005EP1597351A2 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES
11/23/2005EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
11/23/2005EP1597349A2 Methods of screening for trpm5 modulators
11/23/2005EP1597069A2 Nanometer-controlled polymeric thin films that resist adsorption of biological molecules and cells
11/23/2005EP1596871A2 T cell regulation
11/23/2005EP1596834A2 Microparticles comprising polynucleotides adsorbed on the surface of or entrapped within the microparticles
11/23/2005EP1596667A2 Process for concentration of macromolecules
11/23/2005CN1228445C Bacterium and method for producing L-amino acid
11/22/2005US6967091 Lowering circulating free fatty acid levels in an individual by administering to polypeptide and carrier
11/17/2005WO2005059097A3 Methods for high fidelity production of long nucleic acid molecules
11/17/2005WO2005049802A3 Anti-hydroxylase antibodies and uses thereof
11/17/2005WO2005042716A3 Nucleic acid binding oligonucleotides
11/17/2005WO2005037988A3 Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid
11/17/2005WO2004083405A8 Separation and accumulation of subcellular components, and proteins derived therefrom
11/17/2005WO2004073736A8 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
11/17/2005WO2004070006A3 Nucleic acid antigens embedded in thermoplastic
11/17/2005WO2003087321A8 Plant acyl-coa synthetases
11/17/2005US20050255495 SLC5A7 genetic markers associated with age of onset of Alzheimer's disease
11/17/2005US20050255494 CDK5 genetic markers associated with galantamine response
11/17/2005US20050255477 Methods for high fidelity production of long nucleic acid molecules
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005DE10393431T5 Mikroarrays mit mehreren Oligonukleotiden in einzelnen Array Features Microarrays with multiple oligonucleotides in each array features
11/16/2005EP1595238A2 Three dimensional model for protein or part of protein structure
11/16/2005EP1594969A2 Active immunization to generate antibodies to soluble a-beta
11/16/2005EP1594962A2 Covalent tethering of functional groups to proteins
11/16/2005EP1594892A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
11/16/2005EP1594821A2 Process and apparatus for microwave desorption of elements or species from carbon nanotubes
11/16/2005EP1594694A2 Methods and apparatus for pathogen detection and analysis
11/16/2005EP1594549A2 Hypoxia inducible vegf plasmid for ischemic disease
11/16/2005EP1594530A2 Albumin fusion proteins
11/16/2005EP1594476A2 Method and apparatus for treating bodily tissues with medicinal substance
11/16/2005EP1594376A2 Filter containing a metal phthalocyanine and a polycationic polymer
11/16/2005EP1105537B1 Method for determining polynucleotide sequence variations
11/10/2005WO2005049804A3 Engineering enzymes through genetic selection
11/10/2005WO2005030934A8 Methods of preventing restenosis
11/10/2005WO2005014779A3 Cyclodextrin affinity purification
11/10/2005WO2005003318A3 Assay and process for labeling and detection of micro rna and small interfering rna sequences
11/10/2005WO2004113499A3 Modulation of flowering time by the pft1 locus
11/10/2005US20050251883 Dwarfism genes and dwarf plants
11/10/2005US20050250118 EPHX2 Genetic markers associated with galantamine
11/10/2005US20050249718 Compositions and methods for treating disorders associated with abnormal phosphate metabolism
11/09/2005EP1592811A2 Methods for monitoring drug activities in vivo
11/09/2005EP1592806A2 Methos for analyzing global regulation of coding and non-coding rna transcripts involving low molecular weight rnas
11/09/2005EP1592796A2 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2005EP1592795A2 Oligomeric compounds for the modulation of ras expression
11/09/2005EP1592793A2 Oligomeric compounds for the modulation of survivin expression
11/09/2005EP1592791A2 Regulation of gene expression by dna interference
11/09/2005EP1592780A2 Dyrks as modifiers of the apc and axin pathways and methods of use
11/09/2005EP1592779A2 Terminal-phosphate-labeled nucleotides with new linkers
11/09/2005EP1592775A2 Systems and methods for predicting specific genetic loci that affect phenotypic traits
11/09/2005EP1236045B1 Methods of using randomized libraries of zinc finger proteins for the identification of gene function
11/09/2005EP0769024B1 High-affinity melatonin receptors and uses thereof
11/09/2005CN1694967A Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
11/03/2005WO2005101968A2 Antisense oligonucleotides against cpla2, compositions and uses thereof
11/03/2005WO2005044998A3 Enhanced b cell cytotoxicity of cdim binding antibody
11/03/2005WO2005044978A9 Methods of treating, preventing and inhibiting cancer metastasis and tumor formation
11/03/2005WO2005042722A3 Materials and methods for improved sweet corn
11/03/2005WO2005038000A3 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same
11/03/2005WO2005035718A3 Biderectional promoters for small rna expression
11/03/2005WO2005028620A3 Histone modifications as binary switches controlling gene expression
11/03/2005WO2005021722A3 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
11/03/2005WO2005019433A3 VIRALLY-ENCODED RNAs AS SUBSTRATES, INHIBITORS AND DELIVERY VEHICLES FOR RNAi
11/03/2005WO2005014790A3 Polypeptides having oxaloecetate hydrolase activity and polynucleotides encoding same
11/03/2005WO2005007817A3 Hexameric porphobilinogen synthase as a target for the development of antibiotics and herbicides
11/03/2005WO2004072243A3 Macrocyclic hepatitis c serine protease inhibitors
11/03/2005WO2003000842A3 Novel proteins and nucleic acids encoding same
11/03/2005US20050244970 Stem cell libraries
11/03/2005US20050244890 Biomarkers for Alzheimer's disease
11/03/2005US20050244847 Methods and compositions for in vitro amplification of extrachromosomal nucleic acid
11/03/2005US20050244808 Subjecting a zebrafish larva to laser irradiation or exposing a zebrafish to water containing sodium hydroxide; the fish are used for identifing anti-thrombotic agents and for identifying genes associated with all aspects of thrombus formation
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005CA2563741A1 Antisense oligonucleotides against cpla2, compositions and uses thereof
11/02/2005EP1590489A2 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
11/02/2005EP1590488A2 Chemical treatment of biological samples for nucleic acid extraction and kits therefor
11/02/2005EP1590482A2 Nucleic acid amplification using non-standard bases
11/02/2005EP1590446A2 Use of islet 1 as a marker for isolating or generating stem cells
11/02/2005EP1590443A2 Surface expression of biologically active proteins in bacteria
11/02/2005EP1590442A2 Macrocyclic hepatitis c serine protease inhibitors
11/02/2005EP1590439A2 Nucleic acid antigens embedded in thermoplastic
11/02/2005EP1590436A2 Rat receptor tyrosine kinase, kdr
11/02/2005EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/02/2005EP1590433A2 Diagnosis and prognosis of breast cancer patients
11/02/2005CN1690077A Compositions for the therapy and diagnosis of prostate cancer and its uses
10/2005
10/27/2005WO2005052124A3 Modified dna cleaving enzymes and methods of use
10/27/2005WO2005044988A3 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/27/2005WO2005040338A3 Constrained alkaloid immunogens and antibodies and uses thereof
10/27/2005WO2005017122A3 Biocompatibile linkers for surface plasmon resonance biosensors
10/27/2005WO2005007826A3 Production of aromatic carotenoids in gram negative bacteria
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 100